Wassem Juakiem, MD
Gastroenterology · Mobile
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Imc-Diagnostic and Medical Clinic LLC · Singing River Gulfport · Singing River Health System
Hospitals listed: Singing River Gulfport · Singing River Health System. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Juakiem’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C172834 · Delinquent
Licence status: Delinquent · since 2021 · expires 2025-05-31 · Uniformed Services University of the Health Sciences.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Singing River GulfportGulfport, MSAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Singing River Health System, which runs 2 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.382, Oct 2024 – Sep 2025
- Singing River Health SystemPascagoula, MSAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Singing River Health System, which runs 2 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.099, Oct 2024 – Sep 2025
See every measure and the patient survey for Singing River Gulfport
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.382 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 267 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.58 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.7 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 146 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 2,299 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.52) · 1,469 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 104 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.2 (0 to 17.72) · 102 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.88 (0 to 1.95) · 1,058 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.752 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.364 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.495 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.3 · 118 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 307 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.3 · 65 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -27 · 177 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 19.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 251 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (4.9 to 9.1) · 251 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.5 (6.3 to 11.4) · 251 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.4 (11.7 to 20.3) · 520 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
What patients said (289 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 5 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 69% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Singing River Health System
Behind the star rating — Deaths: 0 better, 5 the same, 3 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.099 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.96) · 1,167 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.63 to 1.25) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.69 (133.22 to 222.16) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 20.8 · 268 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.7 · 199 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.7 · 1,677 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.09 to 0.48) · 6,640 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.18 (1.18 to 5.17) · 1,925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.43 (0.89 to 3.96) · 923 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.6 (1.21 to 4) · 1,894 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.17 (3.28 to 15.06) · 950 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.26 (1.75 to 8.76) · 915 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 391 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.11) · 4,402 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 91 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.731 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.32 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.73 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.975 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 202 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 542 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.5 · 146 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.6 · 412 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.4 · 277 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 346 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.2 (4.3 to 8.8) · 209 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (7.6 to 13.7) · 209 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.3 · 274 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (10.1 to 17.6) · 252 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 247 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,104 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$62,592
Medicare paid this office $62,592 for 361 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $10,169 | $85 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 17 | $6,608 | $315 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $4,660 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $4,518 | $94 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 21 | $2,550 | $121 |
See all 17 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $10,169 | $85 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 17 | $6,608 | $315 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $4,660 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $4,518 | $94 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 21 | $2,550 | $121 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 14 | $2,246 | $140 |
| Imaging of digestive tract done from the inside of the digestive tract | 27 | $2,137 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $1,838 | $153 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 22 | $1,691 | $65 |
| Return visit (30+ min) | 21 | $1,566 | $63 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $1,255 | $43 |
| New patient visit (60+ min) | 11 | $1,189 | $108 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $980 | $82 |
| Study of esophagus to assess movement | 19 | $800 | $42 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 18 | $603 | $33 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 22 | $488 | $17 |
| Measurement of liver stiffness | 61 | $460 | $7 |
Procedures Medicare counted
| Colonoscopy | 57 | More than 66% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 214 | More than 91% of doctors who do this |
Who their Medicare patients are
361 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 14% · Women 57% · Also on Medicaid 17% · Health risk score 1.72. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Diabetes 41% · Chronic kidney disease 41% · Heart failure 30% · Depression 29% · Atrial fibrillation 28% · COPD 26% · Cancer 16% · Dementia 14% · Stroke 12%.
The office billed $535,031, Medicare allowed $80,311 and paid $62,592; for 704 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 361 | 704 | 74 | 1.72 | $535,031 | $62,592 |
| 2023 | 331 | 639 | 73 | 1.58 | $447,080 | $63,918 |
| 2022 | 220 | 390 | 72 | 1.46 | $270,424 | $32,058 |
| 2021 | 256 | 368 | 71 | 1.59 | $131,096 | $23,831 |
| 2020 | 284 | 519 | 72 | 2.63 | $207,146 | $41,785 |
| 2019 | 109 | 236 | 72 | 2.05 | $86,746 | $19,954 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $8,535 | $90 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 19 | $6,499 | $309 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $4,649 | $99 |
| New patient visit (60+ min) | 30 | $4,005 | $133 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $3,460 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,189 | $123 |
| Imaging of digestive tract done from the inside of the digestive tract | 33 | $2,676 | $81 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 22 | $2,334 | $83 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,000 | $133 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $1,858 | $155 |
| Return visit (30+ min) | 18 | $1,329 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,027 | $60 |
| Study of esophagus to assess movement | 21 | $984 | $47 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $959 | $80 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 18 | $642 | $36 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 27 | $597 | $18 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $543 | $32 |
| Measurement of liver stiffness | 46 | $343 | $7 |
| Measurement of liver stiffness | 13 | $103 | $8 |
2022: 8 services
| Imaging of digestive tract done from the inside of the digestive tract | 38 | $3,247 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,771 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,824 | $96 |
| Study of esophagus to assess movement | 26 | $1,339 | $50 |
| New patient visit (45+ min) | 12 | $1,228 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,125 | $54 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 26 | $974 | $37 |
| Measurement of liver stiffness | 53 | $427 | $8 |
2021: 10 services
| Imaging of digestive tract done from the inside of the digestive tract | 42 | $3,979 | $95 |
| Return visit (30+ min) | 41 | $3,058 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,362 | $54 |
| New patient visit (45+ min) | 26 | $2,029 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,966 | $98 |
| Study of esophagus to assess movement | 30 | $1,355 | $45 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 31 | $1,064 | $34 |
| Study of rectum sensitivity and function | 11 | $743 | $68 |
| Test for tone and sensation of rectum and anus | 11 | $412 | $37 |
| Measurement of liver stiffness | 43 | $316 | $7 |
2020: 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $11,040 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $8,136 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,411 | $152 |
| Imaging of digestive tract done from the inside of the digestive tract | 33 | $3,474 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $2,923 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,807 | $82 |
| Study of esophagus to assess movement | 25 | $1,212 | $48 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 24 | $905 | $38 |
| Measurement of liver stiffness | 16 | $175 | $11 |
2019: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,412 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $3,893 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $3,462 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,726 | $102 |
| Study of esophagus to assess movement | 13 | $657 | $51 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 13 | $499 | $38 |
Medicaid work
$3,236 in 2021
Medicaid paid $3,236 for 51 billed services this clinician did in 2021, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 23 | $1,880 |
| Return visit (30+ min) | 28 | $1,356 |
| 2021 | 51 | 2 | 27 | $3,236 |
| 2020 | 26 | 1 | 13 | $602 |
See the largest Medicaid services in earlier years
2020
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 26 | $602 |
Drugs they prescribed that Part D paid
$6,011
Pharmacies billed $6,011 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
44 generic and 31 brand-name prescriptions · $6,011 in drug cost · 14 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clenpiq | 17 | $2,919 | $172 |
| Omeprazole | 14 | $105 | $7 |
| Levofloxacin | 11 | $24 | $2 |
Year by year
| 2024 | 75 | 52 | None | 41% | $6,011 |
| 2023 | 55 | 43 | None | 33% | $3,139 |
| 2022 | 29 | 17 | None | None | $1,179 |
| 2021 | 35 | 20 | None | None | $2,204 |
| 2013 | 151 | 12 | None | 58% | $66,088 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Omeprazole | 12 | $95 | $8 |
2013: 3 drugs
| Prezista | 14 | $14,609 | $1,044 |
| Truvada | 11 | $12,865 | $1,170 |
| Norvir | 16 | $6,290 | $393 |
Money from drug and device companies
$166,763 in 2025
| 2025 | 9 | 33 | $165,927 | $166,763 |
| 2024 | 17 | 41 | $90,720 | $93,895 |
| 2023 | 15 | 52 | $120,819 | $122,683 |
| 2022 | 6 | 56 | $91,625 | $96,689 |
| 2021 | 5 | 24 | $33,980 | $35,926 |
| 2020 | 7 | 12 | $1,100 | $1,528 |
| 2019 | 5 | 15 | None | $1,768 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CapsoVision | Capsocam Plus | $164,877 | 18 payments
|
| Micro-tech Endoscopy USA | None | $1,050 | 1 payment
|
| Olympus Corporation of the Americas | Single Use Aspiration Needle Na-U200h | $390 | 5 payments
|
| Steris | None | $158 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $77 | 4 payments
|
See all 33 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-22 | Xifaxan | $24 |
| CapsoVision | Consulting · 2025-12-18 | Capsocam Plus | $4,060 |
| CapsoVision | Consulting · 2025-11-20 | Capsocam Plus | $15,755 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-27 | Xifaxan | $16 |
| Ferring Pharmaceuticals | Meals · 2025-10-27 | Rebyota | $54 |
| Steris | Meals · 2025-10-26 | None | $158 |
| CapsoVision | Consulting · 2025-10-15 | Capsocam Plus | $11,960 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-22 | Xifaxan | $18 |
| CapsoVision | Consulting · 2025-09-17 | Capsocam Plus | $12,190 |
| CapsoVision | Consulting · 2025-08-13 | Capsocam Plus | $10,580 |
| CapsoVision | Consulting · 2025-08-06 | Capsocam Plus | $1,680 |
| Madrigal Pharmaceuticals | Meals · 2025-08-01 | Rezdiffra | $125 |
| CapsoVision | Consulting · 2025-07-24 | Capsocam Plus | $3,220 |
| CapsoVision | Consulting · 2025-07-09 | Capsocam Plus | $10,580 |
| Micro-tech Endoscopy USA | Consulting · 2025-07-02 | None | $1,050 |
| CapsoVision | Consulting · 2025-06-25 | Capsocam Plus | $11,615 |
| CapsoVision | Consulting · 2025-06-11 | Capsocam Plus | $14,773 |
| CapsoVision | Consulting · 2025-05-14 | Capsocam Plus | $6,785 |
| CapsoVision | Consulting · 2025-05-14 | Capsocam Plus | $11,500 |
| CapsoVision | Consulting · 2025-04-16 | Capsocam Plus | $10,235 |
| Olympus America | Meals · 2025-04-02 | Hanarostent Esophagus Tts(Ccc) | $14 |
| CapsoVision | Consulting · 2025-03-12 | Capsocam Plus | $8,625 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $19 |
| CapsoVision | Consulting · 2025-02-20 | Capsocam Plus | $8,050 |
| Olympus Corporation of the Americas | Travel · 2025-01-28 | Single Use Aspiration Needle Na-U200h | $259 |
| Olympus Corporation of the Americas | Meals · 2025-01-24 | Single Use Aspiration Needle Na-U200h | $21 |
| Olympus Corporation of the Americas | Meals · 2025-01-24 | Single Use Aspiration Needle Na-U200h | $54 |
| Olympus Corporation of the Americas | Meals · 2025-01-24 | Single Use Aspiration Needle Na-U200h | $24 |
| CapsoVision | Consulting · 2025-01-23 | Capsocam Plus | $9,315 |
| CapsoVision | Consulting · 2025-01-16 | Capsocam Plus | $7,820 |
| Ironwood Pharmaceuticals | Meals · 2025-01-15 | Linzess | $19 |
| Olympus Corporation of the Americas | Travel · 2025-01-14 | Single Use Aspiration Needle Na-U200h | $31 |
| CapsoVision | Consulting · 2025-01-08 | Capsocam Plus | $6,133 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $93,895
| CapsoVision | Capsocam Colon | $90,745 | 5 payments
|
| Boston Scientific | Axios | $1,123 | 6 payments
|
| Endogastric Solutions | Esophyx | $422 | 4 payments
|
| Olympus Corporation of the Americas | Single Use Aspiration Needle Na-U200h | $371 | 2 payments
|
| Ferring Pharmaceuticals | Rebyota | $274 | 3 payments
|
| Steris | Padlock Clip | $243 | 2 payments
|
| Micro-tech Endoscopy USA | Edgehog | $206 | 2 payments
|
| Celgene | Zeposia | $132 | 7 payments
|
| Stemline Therapeutics | Orserdu | $124 | 1 payment
|
| Fujifilm Healthcare Americas | Fujifilm | $85 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $35 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $35 | 2 payments
|
| PENTAX of America | Inspira | $26 | 1 payment
|
| Abbvie | Creon | $25 | 1 payment
|
| Genzyme | Dupixent | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Eohilia | $16 | 1 payment
|
| Organon | Hadlima | $11 | 1 payment
|
2023: $122,683
| CapsoVision | Capsocam Plus | $120,819 | 14 payments
|
| Olympus Corporation of the Americas | Disposable Distal Attachment | $906 | 7 payments
|
| Boston Scientific | Axios | $224 | 4 payments
|
| Celgene | Zeposia | $129 | 9 payments
|
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $122 | 2 payments
|
| Micro-tech Endoscopy USA | Eyemax | $122 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $112 | 1 payment
|
| Abbvie | Rinvoq | $94 | 4 payments
|
| Genzyme | Dupixent | $52 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $30 | 2 payments
|
| Ardelyx | Ibsrela | $18 | 1 payment
|
| Medtronic | Manoscan | $18 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $15 | 1 payment
|
| Endogastric Solutions | Esophyx | $8 | 1 payment
|
2022: $96,689
| CapsoVision | Capsocam Plus | $91,625 | 15 payments
|
| Boston Scientific | Orise | $3,558 | 29 payments
|
| Olympus Corporation of the Americas | Single Use Electrosurgical Knife Kd-655 | $978 | 7 payments
|
| Steris | Trufreeze | $219 | 2 payments
|
| Abbvie | Skyrizi | $161 | 2 payments
|
| Olympus America | Endocuff Vision | $149 | 1 payment
|
2021: $35,926
| CapsoVision | Capsocam Colon | $33,980 | 10 payments
|
| Boston Scientific | General - Therapies | $917 | 8 payments
|
| Wilson Cook Medical | Instinct | $612 | 2 payments
|
| Olympus America | Single Use Biliary Stent V | $277 | 2 payments
|
| Cook Medical | Instinct | $140 | 2 payments
|
2020: $1,528
| CapsoVision | None | $600 | 2 payments
|
| CapsoPro Services | None | $500 | 1 payment
|
| Boston Scientific | Exalt Model D Controller | $140 | 4 payments
|
| Olympus America | Esd | $126 | 1 payment
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $111 | 1 payment
|
| AbbVie | Humira | $36 | 2 payments
|
| Merck Sharp & Dohme | Zerbaxa | $15 | 1 payment
|
2019: $1,768
| Apollo Endosurgery US | Overstitch | $1,411 | 7 payments
|
| Boston Scientific | General Biliary Devices | $287 | 4 payments
|
| AbbVie | Humira | $45 | 2 payments
|
| Merck Sharp & Dohme | None | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $12 | 1 payment
|
Professional record
- NPI
- 1508177387
- Licence
- CA C172834, MS 26269, VA 0101250946California C172834: Delinquent · expires 2025-05-31
- Group
- Imc-Diagnostic and Medical Clinic LLC · Singing River Gulfport · Singing River Health System
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 301 Fisher St, Biloxi, MS, 39534
- NPI first listed
- 2010-06-28
- NPI last updated
- 2026-08-06
- NPI record certified
- 2026-08-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 15190 Community Rd Ste 240, Gulfport, MS, 39503 · 300 Pasteur Dr, Stanford, CA, 94305